Encore Capital Group Inc (ECPG) Stock Price & How to Invest

Encore Capital Group is one of the two largest publicly traded buyers of charged-off consumer receivables. When a bank or card issuer gives up on a delinquent account, it sells the paper for cents on the dollar, and Encore is one of the buyers. In the United States it collects through Midland Credit Management (MCM), which handles credit card and consumer loan paper; in Europe, mainly the United Kingdom, it operates as Cabot Credit Management, which buys both unsecured consumer debt and some secured and semi-performing portfolios. The business has three moving parts: how much paper Encore buys and at what price, how much cash it eventually collects against that price, and how cheaply it can fund the balance sheet in between. It reported ~$443.8 million of global portfolio purchases in the second quarter of 2026, split ~$372.3 million in the U.S. (a record) and ~$71.5 million in Europe, and collected ~$736.9 million globally in the same quarter.

The investment picture is a heavily leveraged spread business priced for skepticism. At roughly $97.50 a share and a ~$2.07 billion market cap against 2026 guidance of $13.00 to $14.00 in diluted EPS, ECPG trades near seven times guided earnings, and it carries ~$4.18 billion of borrowings. The asset that backs it is estimated remaining collections (ERC) of ~$10.18 billion, up ~9% year over year, which is the undiscounted cash Encore expects to collect over roughly the next 15 years from portfolios it already owns. Bulls point at record U.S. purchasing into what management calls ample supply, record collections, and a cheap multiple. Bears point at the leverage, at the interest expense that leverage carries, at the persistent gap between MCM (strong) and Cabot (flat, and the source of a ~$101 million goodwill charge in early 2025), and at the fact that ERC is an estimate that management itself revises.

The largest single risk is that ERC is a management estimate of cash to be collected over more than a decade, and a downward revision hits both the balance sheet and reported revenue at once, as the ~$101 million goodwill charge attached to weak European results in early 2025 illustrated. Leverage magnifies everything: ~$4.18 billion of borrowings against a ~$2.07 billion equity value means a modest miss on collections or a jump in refinancing rates can move equity value sharply. Regulation is a standing exposure rather than a one-time event, since Encore operates under a history of CFPB enforcement in the U.S. (a 2015 consent order and a 2020 settlement) plus Reg F, the FDCPA, state licensing regimes, and FCA supervision of Cabot in the U.K., and any of those can raise compliance cost or restrict collection methods. Competition for portfolios is the quiet risk, because too much capital chasing the same paper raises purchase prices and depresses returns that will not be visible for several years. A consumer environment that improves sharply would also cut the supply of charged-off paper, while one that deteriorates too far can lift purchase volumes and slow the pace at which people actually pay.

3 analysts publish price targets on ECPG, averaging $115.67 against a $97.50 price as of August 2026, or +18.6%. The published targets run from $112.00 to $120.00, a narrow spread, and the ratings split 3 buy, 1 hold, 0 sell. Over the last six months there have been 6 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full ECPG forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Encore Capital Group Inc. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Supply and purchase pricing in the U.S. Encore's returns are set at the moment of purchase, not at the moment of collection, because the price paid against the eventual collection curve determines the multiple of money it earns. The most optimistic published target, $120.00, assumes this works close to its best case.

The case against. The largest single risk is that ERC is a management estimate of cash to be collected over more than a decade, and a downward revision hits both the balance sheet and reported revenue at once, as the ~$101 million goodwill charge attached to weak European results in early 2025 illustrated. The most pessimistic target, $112.00, is roughly what ECPG is worth if this bites instead.

Read the full bull and bear case on ECPG, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Encore Capital Group Inc's investor relations page or your broker.

• Revenue (TTM): ~$1.90B
• Global collections (Q2 2026): ~$737M
• Diluted EPS (Q2 2026): ~$2.81
• 2026 EPS guidance: ~$13.00 to ~$14.00
• Estimated remaining collections (ERC): ~$10.18B
• Market cap: ~$2.07B

Q2 2026 produced revenue of ~$491.9 million (up ~11%), GAAP net income of ~$64.0 million and diluted EPS of ~$2.81, which included roughly $1.00 per share of costs from the $1 billion refinancing. First-half diluted EPS was ~$6.66 on ~$967.3 million of revenue. Management raised the 2026 collections forecast to ~$2.80 billion to ~$2.85 billion and guided EPS to ~$13.00 to ~$14.00, which puts the ~$97.50 share price near seven times guided earnings. That multiple is low relative to the broader market for a reason: the earnings depend on multi-year collection estimates and are levered on ~$4.18 billion of debt.

Other names that sit close to ECPG: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get ECPG exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so ECPG sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where ECPG fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

ECPG is a leveraged debt-buying business trading at a single-digit multiple of guided earnings, so the outcome turns on purchase-price discipline, the collection curve behind its ~$10.2 billion of estimated remaining collections, and staying out of trouble with U.S. and U.K. regulators.

Whether ECPG is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is ECPG a buy or a sell?, and where the stock could go from here in the ECPG stock forecast.

For income investors, whether ECPG pays a dividend and how the payout looks is covered in does ECPG pay a dividend? And to weigh ECPG against a peer, read the full side-by-side comparisons: ECPG vs BAC and ECPG vs AXP.